A detailed history of Delta Financial Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Delta Financial Advisors LLC holds 19,326 shares of BMY stock, worth $1.11 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
19,326
Previous 16,357 18.15%
Holding current value
$1.11 Million
Previous $679,000 47.28%
% of portfolio
0.36%
Previous 0.26%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$39.66 - $51.75 $117,750 - $153,645
2,969 Added 18.15%
19,326 $1 Million
Q2 2024

Aug 06, 2024

SELL
$40.25 - $52.99 $38,640 - $50,870
-960 Reduced 5.54%
16,357 $679,000
Q1 2024

May 07, 2024

SELL
$47.98 - $54.4 $32,194 - $36,502
-671 Reduced 3.73%
17,317 $939,000
Q4 2023

Jan 31, 2024

SELL
$48.48 - $57.85 $544,478 - $649,713
-11,231 Reduced 38.44%
17,988 $922,000
Q3 2023

Nov 03, 2023

SELL
$57.89 - $64.73 $3,241 - $3,624
-56 Reduced 0.19%
29,219 $1.7 Million
Q2 2023

Aug 03, 2023

BUY
$63.71 - $70.74 $250,762 - $278,432
3,936 Added 15.53%
29,275 $1.87 Million
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $50,793 - $57,611
-773 Reduced 2.96%
25,339 $1.76 Million
Q4 2022

Feb 01, 2023

BUY
$68.48 - $81.09 $2,191 - $2,594
32 Added 0.12%
26,112 $1.88 Million
Q3 2022

Oct 27, 2022

BUY
$0.13 - $76.84 $26 - $15,598
203 Added 0.78%
26,080 $1.85 Million
Q2 2022

Aug 01, 2022

SELL
$72.62 - $79.98 $27,232 - $29,992
-375 Reduced 1.43%
25,877 $1.99 Million
Q1 2022

May 06, 2022

SELL
$61.48 - $73.72 $15,615 - $18,724
-254 Reduced 0.96%
26,252 $1.92 Million
Q4 2021

Feb 04, 2022

BUY
$53.63 - $62.52 $16,357 - $19,068
305 Added 1.16%
26,506 $1.65 Million
Q3 2021

Oct 26, 2021

BUY
$59.17 - $69.31 $9,526 - $11,158
161 Added 0.62%
26,201 $1.55 Million
Q2 2021

Aug 04, 2021

SELL
$61.91 - $67.42 $6,500 - $7,079
-105 Reduced 0.4%
26,040 $1.74 Million
Q1 2021

Apr 29, 2021

BUY
$59.34 - $66.74 $21,481 - $24,159
362 Added 1.4%
26,145 $1.65 Million
Q4 2020

Jan 28, 2021

SELL
$57.74 - $65.43 $21,421 - $24,274
-371 Reduced 1.42%
25,783 $1.6 Million
Q3 2020

Oct 20, 2020

SELL
$57.43 - $63.64 $51,514 - $57,085
-897 Reduced 3.32%
26,154 $1.58 Million
Q2 2020

Aug 04, 2020

SELL
$54.82 - $64.09 $110,407 - $129,077
-2,014 Reduced 6.93%
27,051 $1.59 Million
Q1 2020

Apr 27, 2020

SELL
$46.4 - $67.43 $83,705 - $121,643
-1,804 Reduced 5.84%
29,065 $1.62 Million
Q4 2019

Feb 06, 2020

BUY
$49.21 - $64.19 $566,357 - $738,762
11,509 Added 59.45%
30,869 $1.98 Million
Q3 2019

Oct 30, 2019

BUY
$42.77 - $50.71 $213,422 - $253,042
4,990 Added 34.73%
19,360 $982,000
Q2 2019

Oct 11, 2019

BUY
$44.62 - $49.34 $641,189 - $709,015
14,370 New
14,370 $652,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Delta Financial Advisors LLC Portfolio

Follow Delta Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Financial Advisors LLC with notifications on news.